secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2026-05-27T20:35:28+00:00
Accession:  0001493152-26-025433
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 2.03, 3.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider
--------------------------------------------------------------------------------

- Nasdaq delisting notice due to stockholders' deficit of $983,000 as of March 31, 2026; hearing requested.
- Issued $3,052,788 convertible note to DNA Holdings Venture, Inc. at 10% interest, maturing Dec 31, 2026.
- Note convertible into common at $6.00/share, subject to stockholder approval; proceeds for working capital.
- Concurrently terminated a 'Put Option' under a prior Membership Interest Purchase Agreement.
- Unregistered sale under Section 4(a)(2) and Rule 506(b); Purchaser is an accredited investor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/0001493152-26-025433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-025433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer